Association of the co-stimulator OX40L with systemic lupus erythematosus
- PMID: 19083191
- DOI: 10.1007/s00109-008-0431-2
Association of the co-stimulator OX40L with systemic lupus erythematosus
Abstract
The archetypal systemic autoimmune disease systemic lupus erythematosus (SLE) has incompletely understood pathogenesis, although evidence suggests a strong genetic component. Unlike organ-specific autoimmune diseases such as type 1 diabetes, the genetics of lupus are not as dominated by the effect of a single locus. Undoubtedly, the major histocompatibility complex is the greatest and most consistent genetic risk factor in SLE susceptibility; however, recent candidate gene and whole genome association (WGA) studies have identified several other genes that are likely to advance our understanding of this complex disease. One of these, the TNF superfamily member OX40L, interacts with its unique receptor OX40, to maintain T cell memory by providing a late-stage co-stimulatory signal to sustain the survival of activated T cells. The precise immunological consequences are yet to be determined; however, signalling through OX40-OX40L is bidirectional and the reverse signalling pathway via OX40L may quantitatively enhance B cell proliferation to augment the B cell hyperactivity found in SLE. Like OX40L, several genes recently identified in WGA studies are components of B cell pathways. Collectively, these genes will help us to unravel the mechanisms by which aberrant B cell signalling results in lupus pathogenesis.
Similar articles
-
OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.Ann Saudi Med. 2011 Jan-Feb;31(1):29-34. doi: 10.4103/0256-4947.75775. Ann Saudi Med. 2011. PMID: 21245596 Free PMC article.
-
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.Immunity. 2015 Jun 16;42(6):1159-70. doi: 10.1016/j.immuni.2015.05.012. Epub 2015 Jun 9. Immunity. 2015. PMID: 26070486 Free PMC article.
-
OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.JCI Insight. 2018 Dec 20;3(24):e122167. doi: 10.1172/jci.insight.122167. JCI Insight. 2018. PMID: 30568041 Free PMC article.
-
OX40, OX40L and Autoimmunity: a Comprehensive Review.Clin Rev Allergy Immunol. 2016 Jun;50(3):312-32. doi: 10.1007/s12016-015-8498-3. Clin Rev Allergy Immunol. 2016. PMID: 26215166 Review.
-
OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.Adv Immunol. 2010;105:63-98. doi: 10.1016/S0065-2776(10)05003-0. Adv Immunol. 2010. PMID: 20510730 Review.
Cited by
-
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity.Acta Pharm Sin B. 2020 Mar;10(3):414-433. doi: 10.1016/j.apsb.2019.08.010. Epub 2019 Sep 3. Acta Pharm Sin B. 2020. PMID: 32140389 Free PMC article. Review.
-
Developments in the clinical understanding of lupus.Arthritis Res Ther. 2009;11(5):245. doi: 10.1186/ar2762. Epub 2009 Oct 14. Arthritis Res Ther. 2009. PMID: 19849817 Free PMC article. Review.
-
Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.Arthritis Rheum. 2012 Jan;64(1):222-31. doi: 10.1002/art.33318. Arthritis Rheum. 2012. PMID: 21905002 Free PMC article.
-
Abnormal B Cell Development in Systemic Lupus Erythematosus: What the Genetics Tell Us.Arthritis Rheumatol. 2018 Apr;70(4):496-507. doi: 10.1002/art.40396. Epub 2018 Feb 22. Arthritis Rheumatol. 2018. PMID: 29207444 Free PMC article. Review. No abstract available.
-
OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.Ann Saudi Med. 2011 Jan-Feb;31(1):29-34. doi: 10.4103/0256-4947.75775. Ann Saudi Med. 2011. PMID: 21245596 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical